HDAC9 and Miyoshi myopathy: For instance, the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA)-induced apoptosis in MM and B cell tumor cells, with increased p21 and p53 protein levels, dephosphorylation of Rb, and downregulation of Bcl-2.